North America Autoimmune Drugs Market Size, Share, Growth, and Industry Analysis: Drug Class (Biologics, Small Molecules, Biosimilars), Application (Rheumatoid Arthritis, Psoriasis, Multiple Sclerosis), Regional Insights and Forecast to 2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: North America Autoimmune Drugs Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on North America Autoimmune Drugs Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. North America Autoimmune Drugs Market, Drug Class
   1. Introduction
      1. Market Size and Forecast, Drug Class
   2. Biologics
      1. Market Size and Forecast, By Region
   3. Small Molecules
      1. Market Size and Forecast, By Region
   4. Biosimilars
      1. Market Size and Forecast, By Region
10. North America Autoimmune Drugs Market, Application
    1. Introduction
       1. Market Size and Forecast, Application
    2. Rheumatoid Arthritis
       1. Market Size and Forecast, By Region
    3. Psoriasis
       1. Market Size and Forecast, By Region
    4. Multiple Sclerosis
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. North America
       1. Market Size and Forecast
          1. Drug Class
             1. Biologics
             2. Small Molecules
             3. Biosimilars
          2. Application
             1. Rheumatoid Arthritis
             2. Psoriasis
             3. Multiple Sclerosis
       2. U.S.
          1. Drug Class
             1. Biologics
             2. Small Molecules
             3. Biosimilars
          2. Application
             1. Rheumatoid Arthritis
             2. Psoriasis
             3. Multiple Sclerosis
       3. Canada
12. Competitive Landscape, 2025
    1. Introduction
    2. North America Autoimmune Drugs Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. AbbVie Inc.
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Johnson & Johnson
    3. Pfizer Inc.
    4. Novartis AG
    5. Roche Holding AG
    6. Bristol-Myers Squibb
    7. Eli Lilly and Company
    8. Amgen Inc.
    9. GlaxoSmithKline
    10. Sanofi
    11. AstraZeneca
    12. Biogen Inc.
    13. Takeda Pharmaceutical
    14. Merck & Co.
    15. Regeneron Pharmaceuticals